Northwestern Mutual Wealth Management
OTLK icon

Northwestern Mutual Wealth Management’s Outlook Therapeutics OTLK Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$472 Buy
2,296
+171
+8% +$74 ﹤0.01% 3860
2025
Q4 		$3.36K Hold
2,125
– – ﹤0.01% 3345
2025
Q3 		$2.25K Hold
2,125
– – ﹤0.01% 3359
2025
Q2 		$3.4K Hold
2,125
– – ﹤0.01% 3120
2025
Q1 		$2.59K Hold
2,125
– – ﹤0.01% 3089
2024
Q4 		$4.02K Hold
2,125
– – ﹤0.01% 3007
2024
Q3 		$11.3K Hold
2,125
– – ﹤0.01% 2644
2024
Q2 		$15.7K Hold
2,125
– – ﹤0.01% 2486
2024
Q1 		$25.4K Buy
+2,125
New +$17.2K ﹤0.01% 2329

Other funds holding OTLK

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $126M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NMC
Nine Masts Capital Central, Hong Kong $693M AUM 31.93% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

Northwestern Mutual Wealth Management's OTLK Position: Q1 2026 in Review

Northwestern Mutual Wealth Management increased its Outlook Therapeutics (OTLK) stake by 8% in Q1 2026, buying an estimated $74 and bringing the position to 2,296 shares worth $472. The position accounts for ﹤0.01% of the portfolio, ranked #3860.

Northwestern Mutual Wealth Management first reported a position in OTLK in Q1 2024 and has held it in 9 quarters since. The position peaked at $25.4K in Q1 2024. 54 funds tracked by Wall St. Rank hold OTLK as of Q1 2026.

  • Northwestern Mutual Wealth Management held 2,296 shares of Outlook Therapeutics worth $472 as of Q1 2026.
  • Northwestern Mutual Wealth Management bought 171 Outlook Therapeutics shares in Q1 2026, an estimated $74.
  • Outlook Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3860 holding.
  • Northwestern Mutual Wealth Management first reported a position in Outlook Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • Northwestern Mutual Wealth Management's Outlook Therapeutics position peaked at $25.4K in Q1 2024.
  • 54 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.